Evidence map›Paper›PMID 40689633›Full record

ArticleJournal of bacteriology2025

Artificial cellulose derivatives are metabolized by select human gut Bacteroidota upon priming with common plant β-glucans.

Deepesh Panwar, William A Stewart, Andrew Rodd, Harry Brumer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Glycoside hydrolase-mediated glucomannan catabolism inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Deepesh PanwarMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
William A StewartMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Andrew RoddMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Harry BrumerMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-0101-862X

Funding

Bioindustrial Innovation CanadaCanadian Government | Canadian Institutes of Health Research (CIHR) MOP-142472, PJ9-185659, PJT-189972Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2024-04318
6 · The paper itself

Abstract

Synthetic ethers of cellulose (β(1,4)-glucan) are widely used in the food and pharmaceutical industry as thickeners, gelling agents, emulsifiers, and stabilizers. Consequently, humans ingest significant amounts of artificial cellulose derivatives in diets containing processed foods and through oral drug formulations. In the present study, we examined the potential of mixed-linkage β-glucan (MLG) and xyloglucan (XyG) polysaccharide utilization loci of autochthonous human gut (gastrointestinal tract) Bacteroidota to enable metabolism of artificial cellulose derivatives, based on the commonality of their backbone linkages. Two representative

Indexed as

Bacteroidetesbeta-GlucansCelluloseGastrointestinal MicrobiomeGlucansHumansXylansbeta-GlucansCelluloseGlucansXylansxyloglucanBacteroidesBacteroidotacellulose derivativescellulose ethersfoodhuman diethuman gut microbiotamixed-linkage β-glucanSegatellaxyloglucan

Identifiers

PMID40689633
PMCPMC12369377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.